Fresenius Finalizes Acquisition of mAbxience to Enhance Biosimilars Portfolio Expansion #Madrid #Germany #Biosimilars #mAbxience #Fresenius

mAbxience and Sandoz Team Up to Enhance Global Biosimilar Access #Spain #Madrid #Sandoz #mAbxience #emicizumab